HEADER VIRAL PROTEIN/INHIBITOR 05-OCT-21 7VLQ TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH TITLE 2 PF07321332 IN SPACEGROUP P212121 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.L.ZHOU,F.L.ZHONG,C.LIN,J.ZHANG,J.LI REVDAT 3 29-NOV-23 7VLQ 1 REMARK REVDAT 2 24-AUG-22 7VLQ 1 JRNL REVDAT 1 06-APR-22 7VLQ 0 JRNL AUTH J.LI,C.LIN,X.ZHOU,F.ZHONG,P.ZENG,Y.YANG,Y.ZHANG,B.YU,X.FAN, JRNL AUTH 2 P.J.MCCORMICK,R.FU,Y.FU,H.JIANG,J.ZHANG JRNL TITL STRUCTURAL BASIS OF THE MAIN PROTEASES OF CORONAVIRUS BOUND JRNL TITL 2 TO DRUG CANDIDATE PF-07321332. JRNL REF J.VIROL. V. 96 01321 2022 JRNL REFN ESSN 1098-5514 JRNL PMID 35389231 JRNL DOI 10.1128/JVI.02013-21 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.343 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 51406 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.880 REMARK 3 FREE R VALUE TEST SET COUNT : 3788 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 51.6350 - 5.8147 0.99 3638 147 0.1743 0.2007 REMARK 3 2 5.8147 - 4.6162 1.00 3652 147 0.1725 0.1781 REMARK 3 3 4.6162 - 4.0329 1.00 3635 145 0.1546 0.1506 REMARK 3 4 4.0329 - 3.6643 0.88 3144 125 0.1803 0.1952 REMARK 3 5 3.6643 - 3.4017 0.86 2946 118 0.1970 0.2242 REMARK 3 6 3.4017 - 3.2012 1.00 3653 149 0.1992 0.2159 REMARK 3 7 3.2012 - 3.0409 1.00 3678 146 0.2104 0.2564 REMARK 3 8 3.0409 - 2.9085 1.00 3650 144 0.2066 0.2593 REMARK 3 9 2.9085 - 2.7966 1.00 3658 145 0.2104 0.2528 REMARK 3 10 2.7966 - 2.7001 1.00 3674 150 0.2112 0.2842 REMARK 3 11 2.7001 - 2.6157 0.82 2967 118 0.2158 0.2516 REMARK 3 12 2.6157 - 2.5409 1.00 3655 153 0.2043 0.2276 REMARK 3 13 2.5409 - 2.4740 1.00 3675 147 0.2191 0.2607 REMARK 3 14 2.4740 - 2.4136 1.00 3633 148 0.2182 0.2880 REMARK 3 15 2.4136 - 2.3588 1.00 3652 143 0.2043 0.2305 REMARK 3 16 2.3588 - 2.3086 1.00 3679 145 0.2064 0.2266 REMARK 3 17 2.3086 - 2.2624 1.00 3619 153 0.2028 0.2260 REMARK 3 18 2.2624 - 2.2197 0.67 2470 104 0.2144 0.2628 REMARK 3 19 2.2197 - 2.1801 1.00 3651 145 0.2120 0.2446 REMARK 3 20 2.1801 - 2.1431 1.00 3654 156 0.2158 0.2581 REMARK 3 21 2.1431 - 2.1085 1.00 3605 142 0.2152 0.2729 REMARK 3 22 2.1085 - 2.0761 1.00 3680 144 0.2331 0.2827 REMARK 3 23 2.0761 - 2.0456 0.57 2056 89 0.2456 0.2606 REMARK 3 24 2.0456 - 2.0167 1.00 3658 143 0.2438 0.2914 REMARK 3 25 2.0167 - 1.9895 1.00 3645 149 0.2595 0.2840 REMARK 3 26 1.9895 - 1.9637 0.99 3642 149 0.2686 0.2890 REMARK 3 27 1.9637 - 1.9391 0.99 3574 144 0.2806 0.2970 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.226 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.768 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4630 REMARK 3 ANGLE : 0.950 6332 REMARK 3 CHIRALITY : 0.122 734 REMARK 3 PLANARITY : 0.006 820 REMARK 3 DIHEDRAL : 7.596 2782 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7VLQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1300024862. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51490 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.939 REMARK 200 RESOLUTION RANGE LOW (A) : 51.635 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7CA8 REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN I_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES 7.5, 20% PEG 10000, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.92700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.63500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.00800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.63500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.92700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.00800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 3 REMARK 465 CYS A 300 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 47 CG CD OE1 OE2 REMARK 470 LEU A 67 CG CD1 CD2 REMARK 470 ASN A 72 CG OD1 ND2 REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 LYS A 137 CG CD CE NZ REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 213 CG1 CG2 CD1 REMARK 470 ASN A 277 CG OD1 ND2 REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 299 CG CD OE1 NE2 REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 LEU B 50 CG CD1 CD2 REMARK 470 ARG B 60 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 61 CG CD CE NZ REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP B 155 CG OD1 OD2 REMARK 470 ARG B 188 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 227 CG CD1 CD2 REMARK 470 ASN B 228 CG OD1 ND2 REMARK 470 ASP B 229 CG OD1 OD2 REMARK 470 LEU B 232 CG CD1 CD2 REMARK 470 MET B 235 CG SD CE REMARK 470 LYS B 236 CG CD CE NZ REMARK 470 ASN B 238 CG OD1 ND2 REMARK 470 GLN B 244 CG CD OE1 NE2 REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 LEU B 262 CG CD1 CD2 REMARK 470 LYS B 269 CG CD CE NZ REMARK 470 ASN B 277 CG OD1 ND2 REMARK 470 ILE B 281 CG1 CG2 CD1 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 PHE B 294 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 145 C3 4WI A 401 1.77 REMARK 500 SG CYS B 145 C3 4WI B 401 1.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -132.24 55.16 REMARK 500 ASN A 84 -119.89 48.54 REMARK 500 PRO A 184 41.46 -91.12 REMARK 500 ASP B 33 -126.31 51.08 REMARK 500 ASN B 51 69.96 -157.88 REMARK 500 ASN B 84 -125.63 54.33 REMARK 500 TYR B 154 74.07 41.36 REMARK 500 ASP B 155 -9.09 70.75 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VLQ A 3 302 UNP P0DTC1 R1A_SARS2 3266 3565 DBREF 7VLQ B 3 302 UNP P0DTC1 R1A_SARS2 3266 3565 SEQRES 1 A 300 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 A 300 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 A 300 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 A 300 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 A 300 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 A 300 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 A 300 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 A 300 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 A 300 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 A 300 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 A 300 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 A 300 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 A 300 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 A 300 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 A 300 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 A 300 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 A 300 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 A 300 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 A 300 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 A 300 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 A 300 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 A 300 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 A 300 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 24 A 300 GLY SEQRES 1 B 300 PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU GLY SEQRES 2 B 300 CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU ASN SEQRES 3 B 300 GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG HIS SEQRES 4 B 300 VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN TYR SEQRES 5 B 300 GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE LEU SEQRES 6 B 300 VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SEQRES 7 B 300 SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP THR SEQRES 8 B 300 ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG ILE SEQRES 9 B 300 GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR ASN SEQRES 10 B 300 GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG PRO SEQRES 11 B 300 ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER CYS SEQRES 12 B 300 GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SER SEQRES 13 B 300 PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY VAL SEQRES 14 B 300 HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY PRO SEQRES 15 B 300 PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR ASP SEQRES 16 B 300 THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR ALA SEQRES 17 B 300 ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE SEQRES 18 B 300 THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET LYS SEQRES 19 B 300 TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP ILE SEQRES 20 B 300 LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL LEU SEQRES 21 B 300 ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN GLY SEQRES 22 B 300 MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU GLU SEQRES 23 B 300 ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SER SEQRES 24 B 300 GLY HET 4WI A 401 35 HET 4WI B 401 35 HETNAM 4WI (1R,2S,5S)-N-{(1E,2S)-1-IMINO-3-[(3S)-2-OXOPYRROLIDIN- HETNAM 2 4WI 3-YL]PROPAN-2-YL}-6,6-DIMETHYL-3-[3-METHYL-N- HETNAM 3 4WI (TRIFLUOROACETYL)-L-VALYL]-3-AZABICYCLO[3.1.0]HEXANE- HETNAM 4 4WI 2-CARBOXAMIDE HETSYN 4WI PF-07321332, BOUND FORM; NIRMATRELVIR, BOUND FORM; HETSYN 2 4WI PAXLOVID, BOUND FORM FORMUL 3 4WI 2(C23 H34 F3 N5 O4) FORMUL 5 HOH *200(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 THR A 45 MET A 49 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 HIS A 64 5 3 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 MET A 235 1 10 HELIX 8 AA8 LYS A 236 ASN A 238 5 3 HELIX 9 AA9 THR A 243 LEU A 250 1 8 HELIX 10 AB1 LEU A 250 GLY A 258 1 9 HELIX 11 AB2 ALA A 260 GLY A 275 1 16 HELIX 12 AB3 THR A 292 ARG A 298 1 7 HELIX 13 AB4 SER B 10 GLY B 15 1 6 HELIX 14 AB5 HIS B 41 CYS B 44 5 4 HELIX 15 AB6 GLU B 47 ASN B 51 5 5 HELIX 16 AB7 ASN B 53 ARG B 60 1 8 HELIX 17 AB8 SER B 62 HIS B 64 5 3 HELIX 18 AB9 ILE B 200 ASN B 214 1 15 HELIX 19 AC1 THR B 226 TYR B 237 1 12 HELIX 20 AC2 THR B 243 GLY B 258 1 16 HELIX 21 AC3 ALA B 260 GLY B 275 1 16 HELIX 22 AC4 THR B 292 GLY B 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASP A 153 O CYS A 156 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O THR B 25 N CYS B 22 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O THR B 175 N MET B 162 CRYST1 67.854 102.016 103.270 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014738 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009802 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009683 0.00000